Abivax (AAVXF) Times Interest Earned (2024 - 2025)
Abivax (AAVXF) posted Times Interest Earned of 0.0 for Q4 2025, down 100.13% on a QoQ basis from 1.21 in Q3 2025, and up 87.12% year-over-year from 0.0 in Q4 2024.
Powered by 
Analysis
Abivax (AAVXF) Times Interest Earned (2024 - 2025) Analysis & Trends
Abivax has reported Times Interest Earned for 2 years, with the latest figure at 0.0 in Q4 2025.
- On a quarterly basis, Times Interest Earned rose 87.12% year-over-year to 0.0 in Q4 2025; TTM through Mar 2026 was 0.01, a 74.17% increase from a year earlier, with the FY2025 full-year figure at 0.01, up 55.73% from the prior year.
- Times Interest Earned was 0.0 for Q4 2025 at Abivax, down from 1.21 in the prior quarter.
- The five-year high for Times Interest Earned was 129.88 in Q2 2025, with the low at 0.01 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.88 Bn | 197.89 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 181.55 Bn | 178.37 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 132.31 Bn | 124.45 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 61.54 Bn | 56.36 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 54.69 Bn | 49.55 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.07 Bn | 30.76 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.41 Bn | 30.12 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.10 Bn | 30.10 Bn | 1.16 Mn | - |
| 10 | Abivax | 10.92 Bn | 10.92 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 1.21 |
| Jun 30, 2025 | 129.88 |
| Mar 31, 2025 | 33.59 |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | 28.16 |
| Jun 30, 2024 | 16.56 |
| Mar 31, 2024 | 37.73 |